ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with Aurigene Pharmaceutical Services Limited ("Aurigene Services"), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results